Insulet is primarily engaged in the development, manufacture and sale of its proprietary Omnipod® System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes: the Omnipod Insulin Management System, the Omnipod DASH® Insulin Management System (Omnipod DASH), its digital mobile Omnipod platform and the Omnipod® 5 Automated Insulin Delivery System. The Omnipod System features two devices: the Omnipod device; and the Personal Diabetes Manager. Omnipod DASH features a Bluetooth enabled Pod and PDM with a color touch screen user interface supported by smartphone connectivity and nightly automatic data uploads. The PODD stock yearly return is shown above.
The yearly return on the PODD stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the PODD annual return calculation with any dividends reinvested as applicable (on ex-dates).
|